Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2011
November 1, 2011
- Pfizer Reports Third-Quarter 2011 Results
- Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
- Sanofi Tops Pfizer as Number One for Global Pharma Sales
- Alnylam and GlaxoSmithKline Form Collaboration on RNAi Technology for Vaccine Production
- Broadway Star Ben Vereen Shows Diabetes Doesn't Have to Hold You Back in New Public Service Announcement
- Karo Bio Issues Notice of Redundancy for 25 Employees
- Update Regarding Kitasato Daiichi Sankyo Vaccine's Influenza Ha Vaccine Supply Plan
- Pfizer 3Q Profit Up on Higher Sales, Lower Charges
- Furiex Acquires Full Exclusive License to MuDelta for the Treatment of Diarrhea-Predominant IBS and Reports Positive End of Phase II FDA Meeting
November 2, 2011
- Teva Pharmaceutical 3Q Profit Slides 13 Percent
- Teva Pharmaceutical 3Q Profit Slides 13 Percent
- PPD Announces End of ?Go-Shop? Period and Early Termination of Hart-Scott-Rodino Waiting Period
- Teva Provides Updated 2011 Financial Outlook
- Endo Pharmaceuticals Another Philly Drug Co. Moving
- Lexicon Pharma Posts Smaller 3Q Loss
- Columbus Settles With Genentech Over Ammonia Leak
- Abbott Labs Says FDA clears Xience Prime Stent
- New Drug Shows Promise Against Multiple Sclerosis
- Vanderbilt Study Finds No Heart Risk in ADHD Medications
- Sanofi Reorganizing Research, Trimming Sales Force
- Worries As Glaxo Starts First UK Unit in 30 Years
- Ipsen Sells the North American1 Development and Marketing Rights for Apokyn to Britannia Pharmaceuticals, Achieving A Key Milestone in the Execution of Its New North American Strategy
November 3, 2011
- FDA Panel Backs Expanded use of Merck's Vytorin
- Sanofi: Net sales up 10.1% and Business net income(1) up 4.1% at CER(2)
- Flu-Drug Revenue Falls for Biocryst
- P&G Combining Medical Unit With Israel's Teva
- GlaxoSmithKline Reaches Agreement in Principle to Resolve Multiple Investigations With US Government
- Chantix Unsuitable for First-Line Smoking Cessation Use
- Sanofi Says Net Profit Up 26 Percent
- GlaxoSmithKline in $3 Billion Settlement With US
- ImmunoGen, Inc. Earns Milestone From Amgen With IND Achievement
- Immunogen to Receive $1M Milestone Payment
November 4, 2011
- 'Gray' Drug Marketer Again Under Scrutiny
- Brand Drug 'Copay Coupons' Would Raise Costs By $750 Million for Massachusetts Employers, Unions, and State Employee Health Programs
- FDA Touts Uptick in New Drug Approvals
- FDA Sends Otsuka Letter Regarding Busulfex Website
- New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
- New Structure of Business Operations for a Global Pharmaceutical Company
- Takeda Announces the Conclusion of the Mutual Agreement Procedure Relating to the Correction Notice on Transfer Pricing and Recommencement of the Reinvestigation Process
- U.S. Nutraceutical Market Predicted to Generate 8% CAGR Through 2015: PharmaLive Special Report
- Analyst: Teva to Sell Generic Lipitor This Year
- FDA: 35 innovative new drugs approved in fiscal year 2011
- Takeda Pharmaceutical Reports 5.9% Decline in Net Profit
- AMAG Announces Financial Results for the Third Quarter Ended September 30, 2011
November 7, 2011
- Prescription Pill Overdoses Have Reached Epidemic Proportions Warns Waismann Method Medical Director
- Accentia Biopharmaceuticals Announces Series of Agreements as Part of Debt Reduction Strategy to Strengthen Financial Condition, Improve Balance Sheet and Support Advancement of Immunotherapy Pipeline
- Cubist Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Adolor
- Quintiles Completes Acquisition of Advion BioServices, Creating Full-Spectrum Lab Solution for Drug Development
November 8, 2011
- Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
- Nabi Reviewing Options After Smoking Vaccine Fails
- Baxter Says Immune Drug Reduced Infections
- AstraZeneca Reports Poor Result on Drug Test
- New Jersey Governor Announces Global Healthcare Company Allergan, Inc. Chooses New Jersey as Home for New Research and Development Facility
- Opexa?s Tovaxin for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
- Daiichi Sankyo Brasil and Kyorin Pharmaceutical Reach Agreement in Brazil for Activities Related to the Development and Marketing of Imidafenacin
November 9, 2011
- Chinese Drug Exec Given Suspended Death Sentence
- Mylan to Acquire Pfizer Respiratory Delivery Platform
- Teva firing 1,000 in US and Europe
- Kohl-Grassley Generic Drug Bill Would Save Taxpayers Nearly $4.8 Billion, Congressional Budget Office Says
- Salix Pharma Posts 3Q Profit, Will Buy Oceana
- Affymax Takes Smaller 3Q Loss As Costs Decrease
- Merck Launches Nexplanon Birth Control Implant
November 10, 2011
- Drug Developer Medivation Takes Bigger 3Q Loss
- Medicis 3Q Profit Falls on Payments and Charges
- Breast Cancer Drug not Proven to be Better than Existing Treatments, says Draft Guidance
- Breast Cancer Drug not Proven to be Better than Existing Treatments, says Draft Guidance
- Daiichi Sankyo To License ARQ 092 from ArQule, the First New Compound Resulting from the Companies? Joint AKIP Research Collaboration
- Baxter Completes Acquisition of Baxa Corporation
- Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth
- ArQule Narrows 3Q Loss, Raises 2011 Forecast
- Merck to Seek Approval for Eight New Drugs in 2012-13
- Baxter International Finishes $380 Million Baxa Corp Purchase
November 11, 2011
November 15, 2011
- Geron to Focus on Its Novel Cancer Programs
- Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
- Geron Halts Human Stem Cell Research Trial
- Pfizer Delays Plan for Unit in China to Do Antibacterials Research
- Jab Shows Potential to Lower Bad Cholesterol Levels
- Heart Rhythm Drug Increases Risk Of Death for Some Patients in Halted Study
- Cadence Pharma Raises $67.4M in Stock Offering
- Cadence Plummets After $75M Stock Offering Announced
- NuPathe Plans New Zelrix Filing in Early 2012
- Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
- UCB and PAREXEL Sign Strategic Partnership Agreement
- Gilead Sciences Finalizes Agreement with Tibotec Pharmaceuticals to Develop and Commercialize a Single-Tablet Regimen of Prezista® with Emtriva®, GS 7340 and Cobicistat
November 16, 2011
- Bayer plans further expansion in Asia
- Gilead and J&J Expand HIV Cocktail Partnership
- Tekmira Files for an Injunction in the Supreme Court of British Columbia Seeking Return of Confidential Documents
- Fujifilm and Kyowa Hakko Kirin to Set Up A Joint Venture for the Development of Biosimilars
- Jobs Lost to Asia Reappear in UK
- Apple Names Arthur D. Levinson Chairman of the Board
November 17, 2011
- FDA Panel Backs Pfizer Vaccine for Adults
- Incyte Wins FDA Approval for Pill for Rare Marrow Cancer
- Amarin Says Its Key Drug Is Exceeding Expectations
- Women With Advanced Breast Cancer Denied Life-extending Treatment Halaven (black triangle drug) (Eribulin)
November 18, 2011
- Group DCA Co-founders Davis and Likoff to Retire at Year-end
- Eisai Enters into Japan Co-promotion Agreement with Novartis Pharma for COPD Therapies
- Sarbanes Calls on FTC Commissioner to Take Action Against Pfizer?s Lipitor Deal
- European Medicines Agency Updates on Safety of Pradaxa
- FDA Approves New Childhood Leukemia Treatment
- FDA: Avastin Not Shown to Be Safe and Effective in Breast Cancer Patients
- Bayer Joins List of Multinational Companies Wary of Indian Patent Laws
- Shionogi and Shire to Collaborate on the Development and Commercialization of the Therapeutic Agents for Attention-Deficit/Hyperactivity Disorder
November 21, 2011
- Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion
- Pfizer And MIT Break Ground On New Research Units In Kendall Square
November 22, 2011
- Pfizer to Acquire Excaliard Pharmaceuticals
- Isis to Receive Up to $14 Million from Pfizer for Its Acquisition of Excaliard Pharmaceuticals
- Ferring Pharmaceuticals To Develop Major Corporate Center in Parsippany, New Jersey
- New Study Finds E-prescribing Is Safe and Efficient, but Barriers Remain
- Mass. Governor Celebrates Pfizer Expansion in Cambridge
- Pfizer to Buy Privately Held Excaliard Pharma
- Three Synthes Executives Sentenced to Prison Time
- UCB Acquires Lectus Therapeutics? Key Pharmaceutical Assets
- Dendreon: Medicare Will Cover More Provenge Costs
- Merck Resolves Previously Disclosed Seven-Year Investigation Led by U.S. Attorney's Office for the District of Massachusetts Related to Vioxx
November 23, 2011
- Statins Declared Safe for Heart
- Enbrel (etanercept) Patent Issued
- Celgene Ends Revlimid Prostate Cancer Trial
- Merck to Pay Vioxx Fine, Claims of $950M
- Celgene Will Discontinue Phase III MAINSAIL Trial in Castrate-Resistant Prostate Cancer
- 'Significant' Offenses Cited at Mylan Plant
- FDA Warns Mylan Over Conditions at Plant in Puerto Rico
- Biotie Provides UCB Partnership Update on SYN118
- Surprising Decline in Consumers Seeking Health Information
November 28, 2011
- FDA Approves Middle-of-the-Night Insomnia Pill
- POZEN Monetizes Its Treximet Royalty Stream for $75 Million
November 29, 2011
- Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
- Supreme Court to Hear Pharma Sales Rep OT Appeal
- Analyst Lowers Vertex Target
- Bill Gates Invests Time, Cash Into Drug Research
- Former Executive Sues KV Pharmaceutical
- Dainippon Sumitomo Pharma Announces the Launch of Alzheimer's Disease Treatment Donepezil Hydrochloride Tablets/OD Tablets 3mg/5mg ?DSP?
- Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
November 30, 2011
- Watson Launches Generic Lipitor
- Alexion's Blood Disorder Drug Gets New EU Approval
- Pfizer Trying to Hold on to Lipitor As Patent Expires
- Biogen Says Regulators Cleared Portola Partnership
- Introduction of iPad2 to Activities for Providing Information to Medical Professionals
- Roche to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium
- AstraZeneca Commits An Additional $100 Million to Venture Capital Arm Medimmune Ventures
- Idera Pharmaceuticals Regains Global Rights to IMO-2055 in Oncology from Merck KGaA
- The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hospira, Inc. of Class Action Lawsuit and the Deadline of January 20, 2012 to Seek a Lead Plaintiff Position
- Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories
- Monthly Roundup - November 2011
